Detalhe da pesquisa
1.
Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning.
Eur J Haematol
; 112(3): 350-359, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37823328
2.
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response.
Br J Haematol
; 203(2): 264-281, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37539479
3.
In search for cure of multiple myeloma.
Haematologica
; 2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37981890
4.
An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherence.
Haematologica
; 108(4): 1115-1126, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36325890
5.
General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia.
Haematologica
; 108(7): 1758-1767, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779593
6.
Multidisciplinary tumor board analysis: validation study of a central tool in tumor centers.
Ann Hematol
; 102(3): 603-611, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36464695
7.
Comparison of the prognostic significance of 5 comorbidity scores and 12 functional tests in a prospective multiple myeloma patient cohort.
Cancer
; 127(18): 3422-3436, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34061991
8.
Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network.
Cancer
; 127(18): 3413-3421, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34181755
9.
Geriatric assessments and frailty scores in multiple myeloma patients: a needed tool for individualized treatment?
Curr Opin Oncol
; 33(6): 648-657, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534141
10.
Novel immunotherapies in multiple myeloma - chances and challenges.
Haematologica
; 106(10): 2555-2565, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34196164
11.
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma.
Haematologica
; 106(8): 2054-2065, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792221
12.
Multidisciplinary tumor boards and their analyses: the yin and yang of outcome measures.
BMC Cancer
; 21(1): 173, 2021 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33596881
13.
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis.
Ann Hematol
; 100(9): 2339-2350, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33796897
14.
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT.
Ann Hematol
; 100(8): 2095-2103, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33755792
15.
Two cases of carfilzomib-induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma.
BMC Nephrol
; 22(1): 32, 2021 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33461512
16.
Risk of disease recurrence and survival in patients with multiple myeloma: A German Study Group analysis using a conditional survival approach with long-term follow-up of 815 patients.
Cancer
; 126(15): 3504-3515, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32459378
17.
Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation.
Blood
; 131(13): 1464-1475, 2018 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29348129
18.
APC/CCdh1 regulates the balance between maintenance and differentiation of hematopoietic stem and progenitor cells.
Cell Mol Life Sci
; 76(2): 369-380, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30357422
19.
In-depth cytogenetic and immunohistochemical analysis in a real world cohort - reconsidering the role of primary and secondary aberrations in multiple myeloma.
Haematologica
; 109(1): 318-324, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584288
20.
Comorbidity indices for prognostic evaluation in multiple myeloma: a comprehensive evaluation of the Revised Myeloma Comorbidity Index and other comorbidity indices with pro- and retrospective applications.
Haematologica
; 109(4): 1279-1284, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38031759